Pharma AIDS has recently entered into an agreement with a private company to address the high demand for glass ampoules. Starting from October 1st, 2023, the production of glass ampoules will continue for six months, with the possibility of extension based on performance. Pharma AIDS, listed since 1987, has a paid-up capital of 5 crore taka, with a reserve of 27 crore 72 lakh taka. In the fiscal year ending June 30, 2022, the company distributed a 50% cash dividend to investors, with a net profit of 3 crore 48 lakh taka and an EPS of 11.14 taka.
BIZDATAINSIGHTS
Bizdata Insights is a Market Insights, Data Intelligence and Business Advisory Platform
Our Solutions
Menu
Newsletter
Sign up for our newsletter now by entering your e-mail address and never miss out on the latest news and updates from our team!